Stocktoria
USANA HEALTH SCIENCES INC USNA
USANA HEALTH SCIENCES INC financials (annual)
Bars are annual figures from 2016 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2024 | FY2023 | FY2022 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $925.3M | $854.5M | $921.0M | $998.6M | $1.2B | $1.1B | $1.1B | $1.2B | $1.0B | $1.0B |
| Gross profit | $724.4M | $693.3M | $744.3M | $804.7M | $968.6M | $925.5M | $873.4M | $988.5M | $867.9M | $825.9M |
| R&D expense | $10.7M | $11.6M | $11.4M | $11.6M | $11.1M | $10.6M | $10.3M | $10.2M | $9.0M | $8.8M |
| SG&A expense | $337.4M | $263.3M | $257.0M | $262.3M | $279.1M | $261.2M | $267.7M | $275.1M | $265.1M | $234.2M |
| Operating income | $37.4M | $66.3M | $93.1M | $107.6M | $170.2M | $176.5M | $146.2M | $188.4M | $132.5M | $138.6M |
| Interest expense | — | — | $262,000 | $192,000 | $57,000 | $507,000 | $66,000 | $36,000 | $46,000 | $444,000 |
| Income tax | $30.1M | $34.3M | $38.7M | $39.3M | $54.1M | $53.3M | $50.0M | $65.3M | $72.1M | $38.5M |
| Net income | $10.8M | $42.0M | $63.8M | $69.3M | $116.5M | $124.7M | $100.5M | $126.2M | $62.5M | $100.0M |
| EPS (diluted) | $0.58 | $2.19 | $3.30 | $3.59 | $5.73 | $5.86 | $4.41 | $5.12 | $2.53 | $3.99 |
| Operating cash flow | $22.3M | $61.0M | $70.6M | $103.9M | $121.2M | $160.4M | $126.7M | $152.1M | $123.8M | $137.0M |
| Free cash flow | $8.5M | $50.9M | $56.1M | $93.5M | $108.5M | $145.3M | $110.2M | $140.7M | $110.6M | $104.3M |
| Cash & equivalents | $158.4M | $181.8M | $330.4M | $288.4M | $239.8M | $311.9M | $234.8M | $214.3M | $247.1M | $175.8M |
| Inventory | $102.6M | $69.7M | $61.5M | $67.1M | $98.3M | $90.2M | $68.9M | $81.9M | $62.9M | $64.8M |
| Total assets | $742.9M | $748.2M | $632.8M | $596.5M | $577.7M | $640.9M | $516.9M | $554.5M | $519.3M | $470.6M |
| Total liabilities | $156.6M | $161.9M | $135.6M | — | — | — | — | — | — | — |
| Shareholders' equity | $533.1M | $532.1M | $497.2M | $434.5M | $395.1M | $441.6M | $351.7M | $391.1M | $363.2M | $325.3M |
Growth · year-over-year · Revenue CAGR -0.9%
| Metric | FY2026 | FY2024 | FY2023 | FY2022 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +8.3% | -7.2% | -7.8% | -15.8% | +4.6% | +7.0% | -10.8% | +13.6% | +4.1% | — |
| Net income growth | -74.4% | -34.1% | -8.0% | -40.5% | -6.5% | +24.0% | -20.4% | +101.8% | -37.5% | +5.7% |
| EPS growth | -73.5% | -33.6% | -8.1% | -37.3% | -2.2% | +32.9% | -13.9% | +102.4% | -36.6% | +11.1% |
| Free cash flow growth | -83.3% | -9.3% | -40.0% | -13.8% | -25.4% | +31.9% | -21.7% | +27.3% | +6.0% | +18.9% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2026-01-03. Facts plus Stocktoria's own computed scores — not investment advice.